CONFORMIS
Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, which it refers to as personalized, individualized, or sometimes as customized, to fit each patient’s unique anatomy. Conformis offers a broad line of sterile, personalized knee and hip implants and single-use instruments delivered to hospitals and ambulatory surgical centers.
CONFORMIS
Industry:
Health Care Medical Device Therapeutics
Founded:
2004-01-01
Address:
Burlington, Massachusetts, United States
Country:
United States
Website Url:
http://www.conformis.com
Total Employee:
251+
Status:
Active
Contact:
+1 855 564 7682
Email Addresses:
[email protected]
Total Funding:
523.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins Nginx Amazon
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Stoke Therapeutics
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment.
Current Employees Featured
Founder
Stock Details
Investors List
Innovatus Capital Partners
Innovatus Capital Partners investment in Post-IPO Debt - ConforMIS
East West Bank
East West Bank investment in Post-IPO Debt - ConforMIS
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - ConforMIS
Eaton Gate Capital Partners
Eaton Gate Capital Partners investment in Series E - ConforMIS
SWFI
SWFI investment in Series E - ConforMIS
Axel Johnson
Axel Johnson investment in Series E - ConforMIS
AGC Equity Partners
AGC Equity Partners investment in Series E - ConforMIS
AGC Equity Partners
AGC Equity Partners investment in Series E - ConforMIS
Axel Johnson
Axel Johnson investment in Series E - ConforMIS
Aeris Capital
Aeris Capital investment in Series D - ConforMIS
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-15 | Conformis appoints chief legal officer, corporate secretary |
Official Site Inspections
http://www.conformis.com Semrush global rank: 4.02 M Semrush visits lastest month: 3.07 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
